Activated Leukocyte Cell Adhesion Molecule (ALCAM) Expression is Associated with a Poor Prognosis for Bladder Cancer Patients-Reference-Cited by-同舟云学术

Activated Leukocyte Cell Adhesion Molecule (ALCAM) Expression is Associated with a Poor Prognosis for Bladder Cancer Patients

Published:2003-09 Issue:3-4 Volume:3 Page:121-129
ISSN:1561-0950
Container-title:UroOncology
language:en
Short-container-title:UroOncology

Author:

Tomita* Kyoichi,van Bokhoven† Adrie,Jansen Cornelius F.J.,Kiemeney Lambertus A.,Karthaus Herbert F.M.,Vriesema Jessica,Bussemakers Marion J.G.,Alfred Witjes J.,Schalken Jack A.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology

Link

http://www.tandfonline.com/doi/pdf/10.1080/15610950310001632322

Reference28 articles.

1. Biology and Management of Bladder Cancer

2. Superficial Bladder Cancer: Progression and Recurrence

3. Predictability of Recurrent and Progressive Disease in Individual Patients with Primary Superficial Bladder Cancer

4. RECURRENT OR AGGRESSIVE BLADDER CANCER

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Galectin‐8 inhibition and functions in immune response and tumor biology;Medicinal Research Reviews;2024-04-13

2. Proteome profiling of enzalutamide‐resistant cell lines and serum analysis identified ALCAM as marker of resistance in castration‐resistant prostate cancer;International Journal of Cancer;2022-06-21

3. Establishment of a bladder cancer cell line expressing both mesenchymal and epithelial lineage-associated markers;Human Cell;2020-11-09

4. The role of activated leukocyte cell adhesion molecule (ALCAM) in cancer progression, invasion, metastasis and recurrence: A novel cancer stem cell marker and tumor-specific prognostic marker;Experimental and Molecular Pathology;2020-08

5. Activated leucocyte cell adhesion molecule (ALCAM/CD166) regulates T cell responses in a murine model of food allergy;Clinical and Experimental Immunology;2018-02-20